BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32814228)

  • 1. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
    Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
    Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of microglial activation with white matter changes in dementia with Lewy bodies.
    Nicastro N; Mak E; Williams GB; Surendranathan A; Bevan-Jones WR; Passamonti L; Vàzquez Rodrìguez P; Su L; Arnold R; Fryer TD; Hong YT; Aigbirhio FI; Rowe JB; O'Brien JT
    Neuroimage Clin; 2020; 25():102200. PubMed ID: 32032816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging.
    Nedelska Z; Schwarz CG; Boeve BF; Lowe VJ; Reid RI; Przybelski SA; Lesnick TG; Gunter JL; Senjem ML; Ferman TJ; Smith GE; Geda YE; Knopman DS; Petersen RC; Jack CR; Kantarci K
    Neurobiol Aging; 2015 Jun; 36(6):2010-7. PubMed ID: 25863527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.
    Sarro L; Senjem ML; Lundt ES; Przybelski SA; Lesnick TG; Graff-Radford J; Boeve BF; Lowe VJ; Ferman TJ; Knopman DS; Comi G; Filippi M; Petersen RC; Jack CR; Kantarci K
    Brain; 2016 Oct; 139(Pt 10):2740-2750. PubMed ID: 27452602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies.
    Mak E; Donaghy PC; McKiernan E; Firbank MJ; Lloyd J; Petrides GS; Thomas AJ; O'Brien JT
    Neurobiol Aging; 2019 Jan; 73():74-81. PubMed ID: 30339962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiparametric MRI study of structural brain damage in dementia with lewy bodies: A comparison with Alzheimer's disease.
    Caso F; Agosta F; Scamarcia PG; Basaia S; Canu E; Magnani G; Volontè MA; Filippi M
    Parkinsonism Relat Disord; 2021 Oct; 91():154-161. PubMed ID: 34628194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
    Ye R; Goodheart AE; Locascio JJ; Peterec E; Properzi M; Thibault EG; Chuba E; Johnson KA; Brickhouse MJ; Touroutoglou A; Growdon JH; Dickerson BC; Gomperts SN
    Neurology; 2024 Jun; 102(12):e209460. PubMed ID: 38815233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
    Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
    Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.
    Kantarci K; Schwarz CG; Reid RI; Przybelski SA; Lesnick TG; Zuk SM; Senjem ML; Gunter JL; Lowe V; Machulda MM; Knopman DS; Petersen RC; Jack CR
    JAMA Neurol; 2014 Dec; 71(12):1547-54. PubMed ID: 25347157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies.
    Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
    Mov Disord; 2018 Jul; 33(7):1130-1138. PubMed ID: 29672930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbleeds in dementia with Lewy bodies.
    Donaghy PC; Firbank M; Mitra D; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
    J Neurol; 2020 May; 267(5):1491-1498. PubMed ID: 32016624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology.
    van der Zande JJ; Steenwijk MD; Ten Kate M; Wattjes MP; Scheltens P; Lemstra AW
    Neurobiol Aging; 2018 Nov; 71():171-178. PubMed ID: 30149288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies.
    Singh NA; Goodrich AW; Graff-Radford J; Machulda MM; Sintini I; Carlos AF; Robinson CG; Reid RI; Lowe VJ; Jack CR; Petersen RC; Boeve BF; Josephs KA; Kantarci K; Whitwell JL
    Neuroimage; 2024 Apr; 290():120564. PubMed ID: 38442778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI.
    Kantarci K; Avula R; Senjem ML; Samikoglu AR; Zhang B; Weigand SD; Przybelski SA; Edmonson HA; Vemuri P; Knopman DS; Ferman TJ; Boeve BF; Petersen RC; Jack CR
    Neurology; 2010 Jun; 74(22):1814-21. PubMed ID: 20513818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging.
    Watson R; Blamire AM; Colloby SJ; Wood JS; Barber R; He J; O'Brien JT
    Neurology; 2012 Aug; 79(9):906-14. PubMed ID: 22895591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer's disease.
    Firbank MJ; Blamire AM; Krishnan MS; Teodorczuk A; English P; Gholkar A; Harrison R; O'Brien JT
    Neuroimage; 2007 May; 36(1):1-7. PubMed ID: 17412610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.
    Siderowf A; Pontecorvo MJ; Shill HA; Mintun MA; Arora A; Joshi AD; Lu M; Adler CH; Galasko D; Liebsack C; Skovronsky DM; Sabbagh MN
    BMC Neurol; 2014 Apr; 14():79. PubMed ID: 24716655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.